Faster cognitive decline in elders without dementia and decreased risk of cancer mortality

Neurology

Volumn 82, Issue 16, 2014, Pages 1441-1448

  Benito León, Julián ^a,b   Romero, Juan Pablo ^a   Louis, Elan D ^c,d,e   Bermejo Pareja, Félix ^a,b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c Vagelos College of Physicians and Surgeons   (United States)

^d NONE   (United States)

^e Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; COMORBIDITY; DEATH CERTIFICATE; DEMENTIA; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DIGESTIVE SYSTEM CANCER; FOLLOW UP; HEART DISEASE; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OSTEOPOROSIS; OVERALL SURVIVAL; PERITONEUM CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; UROGENITAL TRACT CANCER; ALZHEIMER DISEASE; CAUSE OF DEATH; CLASSIFICATION; CROSS-SECTIONAL STUDY; ESSENTIAL TREMOR; FEMALE; HEALTH SURVEY; INDEPENDENT LIVING; KAPLAN MEIER METHOD; LONGITUDINAL STUDY; MENTAL HEALTH; MILD COGNITIVE IMPAIRMENT; MORTALITY; NEOPLASM; PARKINSON DISEASE; PROPORTIONAL HAZARDS MODEL; PSYCHOMETRY; RISK; SPAIN; STATISTICS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CAUSE OF DEATH; CROSS-SECTIONAL STUDIES; ESSENTIAL TREMOR; FEMALE; HEALTH SURVEYS; HUMANS; INDEPENDENT LIVING; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MENTAL STATUS SCHEDULE; MILD COGNITIVE IMPAIRMENT; NEOPLASMS; PARKINSON DISEASE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PSYCHOMETRICS; RISK; SPAIN; STATISTICS AS TOPIC; STROKE;

EID: 84901832730     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000350     Document Type: Article

References (40)

1. Roe CM, Fitzpatrick AL, Xiong C, et al. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 2010; 74: 106-112.
2. Driver JA, Beiser A, Au R, et al. Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ 2012; 344: e1442.
3. Romero JP, Benito-León J, Louis ED, Bermejo-Fareja F. Alzheimer's disease is associated with decreased risk of cancer-specific mortality: a prospective study (NEDICES). J Alzheimers Dis 2014. [Epub ahead of print].
4. Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 1999; 66: 137-147. (Pubitemid 29103513)
5. Tavares AR Jr, de Melo AC, Sternberg C. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 2010; 75: 1215-1216.
6. Jones RW. Inflammation and Alzheimer's disease. Lancet 2001; 358: 436-437. (Pubitemid 32769846)
7. Engelhart MJ, Geerlings MI, Meijer J, et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch Neurol 2004; 61: 668-672. (Pubitemid 38637682)
8. Haabeth OA, Lorvik KB, Hammarstrom C, et al. Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun 2011; 2: 240.
9. Kinnunen PJ. Cancer linked to Alzheimer disease but not vascular dementia. Neurology 2010; 75: 1215.
10. Harris F, Dennison SR, Phoenix DA. Aberrant action of amyloidogenic host defense peptides: a new paradigm to investigate neurodegenerative disorders? FASEB J 2012; 26: 1776-1781.
11. Bennett DA, Leurgans S. Is there a link between cancer and Alzheimer disease? Neurology 2010; 74: 100-101.
12. Benito-León J, Bermejo-Pareja F, Rodríguez J, et al. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain. Mov Disord 2003; 18: 267-274. (Pubitemid 36410822)
13. Benito-León J, Bermejo-Pareja F, Morales-González JM, et al. Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology 2004; 62: 734-741. (Pubitemid 38298949)
14. Benito-León J, Bermejo-Pareja F, Morales JM, Vega S, Molina JA. Prevalence of essential tremor in three elderly populations of central Spain. Mov Disord 2003; 18: 389-394. (Pubitemid 36527279)
15. Benito-León J, Bermejo-Pareja F, Louis ED; Neurological Disorders in Central Spain (NEDICES) Study Group. Incidence of essential tremor in three elderly populations of central Spain. Neurology 2005; 64: 1721-1725. (Pubitemid 40695805)
16. Díaz-Guzman J, Bermejo-Pareja F, Benito-León J, et al. Prevalence of stroke and transient ischemic attack in three elderly populations of central Spain. Neuroepidemiology 2008; 30: 247-253. (Pubitemid 351871656)
17. Martínez-Salio A, Benito-León J, Díaz-Guzman J, Bermejo-Pareja F. Cerebrovascular disease incidence in central Spain (NEDICES): a population-based prospective study. J Neurol Sci 2010; 298: 85-90.
18. Bermejo-Pareja F, Benito-León J, Vega S, et al. Consistency of clinical diagnosis of dementia in NEDICES: a population-based longitudinal study in Spain. J Geriatr Psychiatry Neurol 2009; 22: 246-255.
19. Bermejo-Pareja F, Benito-León J, Vega S, Medrano MJ, Roman GC; Neurological Disorders in Central Spain (NEDICES) Study Group. Incidence and subtypes of dementia in three elderly populations of central Spain. J Neurol Sci 2008; 264: 63-72. (Pubitemid 350193244)
20. Villarejo A, Benito-León J, Trincado R, et al. Dementia-associated mortality at thirteen years in the NEDICES Cohort Study. J Alzheimers Dis 2011; 26: 543-551.
21. Morales JM, Bermejo FP, Benito-León J, et al. Methods and demographic findings of the baseline survey of the NEDICES cohort: a door-to-door survey of neurological disorders in three communities from Central Spain. Public Health 2004; 118: 426-433. (Pubitemid 39157819)
22. Vega S, Benito-León J, Bermejo-Pareja F, et al. Several factors influenced attrition in a population-based elderly cohort: neurological disorders in Central Spain Study. J Clin Epidemiol 2010; 63: 215-222.
23. Bermejo-Pareja F, Benito-León J, Vega QS, et al. The NEDICES cohort of the elderly: methodology and main neurological findings [in Spanish]. Rev Neurol 2008; 46: 416-423. (Pubitemid 351767911)
24. Benito-León J, Louis ED, Rivera-Navarro J, Medrano MJ, Vega S, Bermejo-Pareja F. Low morale is associated with increased risk of mortality in the elderly: a population-based prospective study (NEDICES). Age Ageing 2010; 39: 366-373.
25. Benito-León J, Louis ED, Bermejo-Pareja F; Neurological Disorders in Central Spain Study Group. Population-based case-control study of morale in Parkinson's disease. Eur J Neurol 2009; 16: 330-336.
26. Louis ED, Benito-León J, Bermejo-Pareja F; Neurological Disorders in Central Spain Study Group. Self-reported depression and anti-depressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based study. Eur J Neurol 2007; 14: 1138-1146. (Pubitemid 47459747)
27. Benito-León J, Louis ED, Bermejo-Pareja F; Neurological Disorders in Central Spain Study Group. Population-based case-control study of cognitive function in essential tremor. Neurology 2006; 66: 69-74. (Pubitemid 43739595)
28. Benito-León J, Louis ED, Vega S, Bermejo-Pareja F. Statins and cognitive functioning in the elderly: a population-based study. J Alzheimers Dis 2010; 21: 95-102.
29. Benito-León J, Mitchell AJ, Vega S, Bermejo-Pareja F. A population-based study of cognitive function in older people with subjective memory complaints. J Alzheimers Dis 2010; 22: 159-170.
30. Benito-León J, Louis ED, Posada IJ, et al. Population-based case-control study of cognitive function in early Parkinson's disease (NEDICES). J Neurol Sci 2011; 310: 176-182.
31. Benito-León J, Louis ED, Bermejo-Pareja F. Cognitive decline in short and long sleepers: a prospective population-based study (NEDICES). J Psychiatr Res 2013; 47: 1998-2003.
32. Benito-León J, Louis ED, Sánchez-Ferro A, Bermejo-Pareja F. Rate of cognitive decline during the premotor phase of essential tremor: a prospective study. Neurology 2013; 81: 60-66.
33. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association; 1994.
34. Vanacore N, Spila-Alegiani S, Raschetti R, Meco G. Mortality cancer risk in parkinsonian patients: a population-based study. Neurology 1999; 52: 395-398. (Pubitemid 29059073)
35. Sorensen SA, Fenger K. Causes of death in patients with Huntington's disease and in unaffected first degree relatives. J Med Genet 1992; 29: 911-914. (Pubitemid 23035219)
36. Mormino EC, Kluth JT, Madison CM, et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 2009; 132: 1310-1323.
37. Oh H, Madison C, Haight TJ, Markley C, Jagust WJ. Effects of age and beta-amyloid on cognitive changes in normal elderly people. Neurobiol Aging 2012; 33: 2746-2755.
38. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004; 292: 2237-2242. (Pubitemid 39473161)
39. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry 2008; 64: 484-490.
40. Pérez-Gomez B, Aragonés N, Pollan M, et al. Accuracy of cancer death certificates in Spain: a summary of available information. Gac Sanit 2006; 20(suppl 3): 42-51.